Leflunomid Stada

Leflunomide, the active ingredient in Leflunomid Stada, is an immunomodulatory agent presented as an oral formulation for oral administration. It modulates the immune response and is indicated for the treatment of rheumatoid arthritis and psoriatic arthritis in adult patients, helping to reduce inflammation and slow disease progression.

GNH USA supplies Leflunomid Stada as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics across global markets while adhering to stringent quality and regulatory standards, and ensuring reliable delivery timelines.

Leflunomide is employed to manage autoimmune inflammatory disorders that affect the joints and skin.

- Rheumatoid arthritis: reduces disease activity, slows joint damage, and improves functional ability. - Psoriatic arthritis: alleviates joint inflammation and skin lesions, enhancing overall disease control. - Active disease in adult patients: provides disease‑modifying benefits to control progression.

Leflunomide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Diarrhea: loose stools or increased frequency. - Nausea: feeling of sickness or urge to vomit. - Alopecia: thinning or loss of hair. - Elevated liver enzymes: increased ALT/AST levels.

Serious or Rare Side Effects: - Severe liver injury: hepatitis or hepatic failure. - Bone marrow suppression: anemia, leukopenia, or thrombocytopenia. - Stevens‑Johnson syndrome: severe skin and mucosal reaction. - Teratogenic effects: fetal malformations if exposure occurs during pregnancy.

Before initiating therapy, several safety considerations should be observed.

- Pregnancy contraindication: avoid use in pregnancy due to high teratogenic risk. - Liver monitoring: perform baseline and periodic liver function tests. - Infection risk: screen for active infections before initiating therapy. - Live vaccines: do not administer live vaccines during treatment. - Concomitant nephrotoxic drugs: use caution with agents that may impair renal function. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Leflunomide can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect and bleeding risk. - Carbamazepine: induces metabolism, reducing leflunomide efficacy. - Live vaccines: heightened risk of infection.

Moderate Interactions (Monitor Closely): - Statins: increased risk of myopathy. - Methotrexate: combined hepatotoxic potential. - NSAIDs: additive gastrointestinal irritation.